Cubist Systematic Strategies, LLC Ocular Therapeutix, Inc Transaction History

Cubist Systematic Strategies, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.85 - $10.93 $1.29 Million - $3.67 Million	336,132 New	336,132 $3.06 Million
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $119,939 - $269,541	42,989 New	42,989 $226,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $34,004 - $54,041	8,314 Added 20.84%	48,210 $200,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $20,034 - $34,744	6,656 Added 20.02%	39,896 $160,000
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $724,471 - $1.1 Million	-149,994 Reduced 81.86%	33,240 $165,000
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $565,888 - $1.11 Million	91,865 Added 100.54%	183,234 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $651,093 - $962,543	67,123 Added 276.84%	91,369 $914,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $325,623 - $464,553	24,246 New	24,246 $344,000
Q1 2021 May 17, 2021	SELL	$15.82 - $22.11 $276,644 - $386,637	-17,487 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $89,786 - $260,505	-11,351 Reduced 39.36%	17,487 $362,000
Q3 2020 Nov 16, 2020	BUY	$7.36 - $9.87 $74,483 - $99,884	10,120 Added 54.07%	28,838 $219,000
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $87,413 - $167,526	18,718 New	18,718 $156,000

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $643M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.